SUVEN PHARMACEUTICALS
Back to Cashflow Statement
|
SUVEN PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-18 Cr | ₹20 Cr | ₹37 Cr | ₹-4.51 Cr | ₹0.79 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SUVEN PHARMACEUTICALS ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹-18 Cr |
Mar2023 | ₹20 Cr |
Mar2022 | ₹37 Cr |
Mar2021 | ₹-4.51 Cr |
Mar2020 | ₹0.79 Cr |
How is Net Cash Inflow / Outflow of SUVEN PHARMACEUTICALS Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹-18 Cr | Negative | |
Mar2023 | ₹20 Cr | -45.86 | |
Mar2022 | ₹37 Cr | Positive | |
Mar2021 | ₹-4.51 Cr | Negative | |
Mar2020 | ₹0.79 Cr | - |
Compare Net Cash Inflow / Outflow of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹29,193.7 Cr | -7% | -2.3% | 77.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,910.0 Cr | 5.4% | 3.2% | 20.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,035.0 Cr | 1.9% | 2% | 59.4% | Stock Analytics | |
CIPLA | ₹125,540.0 Cr | 1.7% | 2% | 13.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,894.0 Cr | 2.8% | 2.3% | 22.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,110.0 Cr | 2.1% | -0.9% | -1.5% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | -7% |
-2.3% |
77.6% |
SENSEX | 1% |
4.3% |
8.9% |
You may also like the below Video Courses